Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,658 | 2,176 | 22,095 | 97 | 55 |
| Marketable Securities | 34,022 | 19,522 | 28,008 | N/A | 517 |
| Receivables | N/A | 428 | 115 | 83 | 95 |
| TOTAL | $52,346 | $22,126 | $50,218 | $180 | $667 |
| Non-Current Assets | |||||
| PPE Net | 227 | 97 | 49 | 18 | 25 |
| Other Non-Current Assets | 19,110 | 95 | 57 | 3 | 512 |
| TOTAL | $19,337 | $192 | $106 | $21 | $537 |
| Total Assets | $71,683 | $22,318 | $50,324 | $201 | $1,204 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 662 | N/A |
| Accounts payable and accrued liabilities | 57 | 305 | 47 | 23 | 124 |
| Accrued Expenses | 2,295 | 2,070 | 1,589 | 83 | 95 |
| TOTAL | $2,352 | $2,375 | $1,636 | $768 | $219 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,352 | $2,375 | $1,636 | $768 | $219 |
| Shareholders' Equity | |||||
| Common Shares | 74 | 39 | 39 | 4 | 4 |
| Retained earnings | -71,017 | -51,568 | -18,734 | -8,186 | -6,607 |
| TOTAL | $69,331 | $19,943 | $48,688 | $-567 | $985 |
| Total Liabilities And Equity | $71,683 | $22,318 | $50,324 | $201 | $1,204 |